The biology of human natural killer-cell subsets

Trends in Immunology

Volumn 22, Issue 11, 2001, Pages 633-640

  Cooper, Megan A ^a   Fehniger, Todd A ^a   Caligiuri, Michael A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; CELL ADHESION MOLECULE; CELL RECEPTOR; CHEMOKINE; CYTOKINE; FC RECEPTOR; IMMUNOGLOBULIN;

BONE MARROW TRANSPLANTATION; CELL ACTIVATION; CELL FUNCTION; CELL MATURATION; CELL SUBPOPULATION; CELL SURFACE; CYTOKINE PRODUCTION; CYTOLOGY; CYTOLYSIS; CYTOTOXICITY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; SENSITIZATION;

ANIMALS; ANTIGENS, CD56; CELL ADHESION MOLECULES; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MODELS, IMMUNOLOGICAL; RECEPTORS, CHEMOKINE; RECEPTORS, CYTOKINE; RECEPTORS, IMMUNOLOGIC;

EID: 0035499063     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(01)02060-9     Document Type: Review

References (65)

1. Biology and clinical relevance of human natural killer cells
2. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes
3. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule
4. Involvement of CD56 (NKH-1/Leu-19 antigen) as an adhesion molecule in natural-killer-target-cell interaction
5. Evidence for the involvement of CD56 molecules in alloantigen-specific recognition by human natural killer cells
6. Modification of P-selectin glycoprotein ligand 1 with a natural-killer-cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin
7. Participation of the CD94 receptor complex in costimulation of human natural killer cells
8. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells
9. Functional consequences of interleukin-2 receptor expression on resting human lymphocytes. Identification of a novel natural-killer-cell subset with high-affinity receptors
10. - natural killer cells in vivo
11. Characterization of the interleukin-2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: Association of the p64 IL-2Rγ chain with the IL-2Rβ chain in functional intermediate-affinity IL-2R
12. Expression of a functional c-kit receptor on a subset of natural killer cells
13. Interleukin-1β costimulates interferon-γ production by human natural killer cells
14. Constitutive and induced IL-18 receptor expression by various peripheral-blood-cell subsets as determined by anti-hIL-18R monoclonal antibody
15. + NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire
16. dim natural-killer-cell subsets
17. bright+ natural-killer-cell subpopulations
18. Turning on natural killer cells
19. Activating receptors and coreceptors involved in human natural-killer-cell-mediated cytolysis
20. NK cell receptors
21. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
22. ULBPs, novel MHC-class-I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
23. Involvement of natural cytotoxicity receptors in human natural-killer-cell-mediated lysis of neuroblastoma and glioblastoma cell lines
24. Signal transduction during natural-killer-cell activation: Inside the mind of a killer
25. Selective modulation of human natural killer cells in vivo after prolonged infusion of low-dose recombinant interleukin-2
26. Differential responses to interleukin-2 define functionally distinct subsets of human natural killer cells
27. The c-kit ligand suppresses apoptosis of human natural killer cells through the up-regulation of bcl-2
28. The functional characterization of interleukin-10 receptor expression on human natural killer cells
29. Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4
30. Interleukin (IL)-15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor
31. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: Implications for the innate immune response
32. Expression and regulation of chemokine receptors in human natural killer cells
33. Chemokines and the arrest of lymphocytes rolling under flow conditions
34. bright natural-killer-cell subsets: Characterization of distinct functional responses to interleukin-2 and the c-kit ligand
35. Interleukin-2
36. Human natural-killer-cell adhesion molecules. Differential expression after activation and participation in cytolysis
37. Functional expression of CD43 on human natural killer cells
38. - lymphocytes (NK cells)
39. On guard-activating NK cell receptors
40. Comparative studies of human FcRIII-positive and -negative natural killer cells
41. Response of human natural killer (NK) cells to NK-cell stimulatory factor (NKSF): Cytolytic activity and proliferation of NK cells are differentially regulated by NKSF
42. + natural-killer-cell subsets and its induction by interleukin-2
43. Cooperation of natural-killer-cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells
44. bright subset
45. Differentiation of human NK cells into NK1 and NK2 subsets
46. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
47. Costimulatory signals are required for optimal proliferation of human natural killer cells
48. + hematopoietic progenitor cells
49. Natural-killer-cell differentiation: Insights from knockout and transgenic mouse models and in vitro systems
50. Reversible defects in natural killer and memory CD8 T-cell lineages in interleukin-15-deficient mice
51. Interleukin-15: Biology and relevance to human disease
52. + human natural-killer-cell progenitor that responds to interleukin-15
53. The role of natural killer cells in innate resistance to infection
54. Interleukin-21 and its receptor are involved in NK-cell expansion and regulation of lymphocyte function
55. Human natural killer cells with polyclonal lectin and immunoglobulin-like receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2
56. Functions of human decidual NK cells
57. NK phenotypic markers and IL-2 response in NK cells from elderly people
58. + cells in bone marrow transplant recipients
59. + natural killer cells after bone-marrow transplantation
60. Role of natural-killer-cell alloreactivity in HLA-mismatched hematopoietic stem-cell transplantation
61. Cytokine replacement in patients with HIV-1 non-Hodgkin's lymphoma: The rationale for low-dose interleukin-2 therapy
62. Potential mechanisms of human natural-killer-cell expansion in vivo during low-dose IL-2 therapy
63. Monoclonal antibody therapies - A 'constant' threat to cancer
64. Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets
65. Ontogeny and expansion of human natural killer cells: Clinical implications